[IAG regimen for patients with refractory/relapsed acute myeloid leukemia]

Zhonghua Xue Ye Xue Za Zhi. 2013 Jul;34(7):637-8. doi: 10.3760/cma.j.issn.0253-2727.2013.07.020.
[Article in Chinese]
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cytarabine / administration & dosage
  • Daunorubicin / administration & dosage
  • Female
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*
  • Male
  • Middle Aged
  • Young Adult

Substances

  • Cytarabine
  • Daunorubicin